Author:
Goodnough D. B.,Baker G. B.
Reference29 articles.
1. Amsterdam JD, Berwish NJ (1989) High dose tranylcypromine treatment for refractory depression. Pharmacopsychiatry 22: 21–25.
2. Baker GB, Hiob LE, Dewhurst WG (1980) Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytrypamine from rat striatum in vitro. Cell Mol Biol 26: 182–186.
3. Baker GB, McKim HR, Calverley DG, Dewhurst WG (1978) Effects of the monoamine oxidase inhibitors tranylcypromine, phenelzine, and pheniprazine of the uptake of catecholamines in slices from rat brain regions. Proc Eur Soc Neurochem 1: 536.
4. Baker GB, Coutts RT, Rao TS (1987) Neuropharmacological and neurochemical properties of N-(cyanoethyl)-2-phenethylamine, a prodrug of 2-phenethylamine. Br J Pharmacol 92: 243–255.
5. Baker GB, Greenshaw AJ (1989) Effects of long-term administration of antidepressants on receptors in the central nervous system. Cell Mol Biol 9: 1–44.